切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - YES - Cdc7 - Thymidylate Synthase - Inward Rectifier Potassium (Kir) Channels

13件产品中的 1-10

页面
每页
清除全部
  1. SU6656
    B5839 SU6656
    Target: Src|Lyn|YES|Fyn
    Summary: Src 酪氨酸激酶抑制剂
      ≥18.55 mg/mL
      insoluble in H2O
  2. Raltitrexed
    B1476 Raltitrexed
    中文名: 雷替曲塞
    Target: Thymidylate Synthase
    Summary: 胸苷酸合酶抑制剂
      ≥154 mg/mL
      insoluble in H2O
  3. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  4. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  5. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  6. XL413
    B1232 XL413
    Target: Cdc7
    Summary: Cdc7抑制剂
      Soluble in DMSO
  7. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  8. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  9. PHA-767491
    A3721 PHA-767491
    Target: Cyclin-Dependent Kinases|MK2|Cdc7
    Summary: Cdc7 / CDK9抑制剂
      ≥10.65 mg/mL
      insoluble in H2O
  10. Pemetrexed
    A4390 Pemetrexed
     1 Citation
    中文名: 培美曲塞二钠盐
    Target: Thymidylate Synthase|DHFR|GARFT
    Summary: TS、DHFR、GARFT和AICARFT抑制剂
      ≥15.68 mg/mL
      ≥30.67 mg/mL

13件产品中的 1-10

页面
每页